Literature DB >> 6965902

Further heterogeneity demonstrated for serum creatine kinase isoenzyme MM.

J P Chapelle, C Heusghem.   

Abstract

Serum creatine kinase (EC 2.1.3.2) isoenzyme MM was resolved by isoelectric focusing into a five-band pattern, a pattern that gradually changed after the onset of myocardial infarction. Similar changes were also demonstrated in patients undergoing coronary-bypass surgery. The evolution of two CK-MB sub-bands was studied in both cases. We found that three electrophoretic bands (CK-MM, pI 7.10; MM1, pI 6.88; MB1, pI 5.61) were predominant in patterns for sera collected during the early phase of myocardial infarction, but rapidly disappeared during the following hours, whereas bands of increased electrophoretic mobility (MM2, pI 6.70; MM3, pI 6.45; MM4, pI 6.25; MB2, pI 5.34) gradually increased. MM3 was always the major band at the end of the observation period in acute myocardial infarction (mean, 61.4% of total creatine kinase activity 36 h after the peak value for total creatine kinase in serum). The CK-MM bands were also present in the serum of patients without heart disease. Changes in the electrophoretic pattern were induced by a thermolabile factor in normal human serum, which transformed the muscular or myocardial MM and MM1 bands after their release into the blood stream.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6965902

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  Molecular mechanism for the production of multiple forms of MM creatine kinase.

Authors:  M B Perryman; J D Knell; R Roberts
Journal:  Experientia       Date:  1984-11-15

2.  Derivation of a bioclinical prognostic index in severe head injury.

Authors:  P Hans; A Albert; J D Born; J P Chapelle
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

3.  Identification by isoelectric focusing of creatine kinase-MM isoforms in the plasma and striated muscle of pigs.

Authors:  F Doizé; L Deroth
Journal:  Vet Res Commun       Date:  1991       Impact factor: 2.459

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.